State-of-the-Art PaperCardiovascular Complications of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management
Under an Elsevier user license
open archive
Key Words
cancer
cardiotoxicity
therapy
heart failure
Abbreviations and Acronyms
ACE
angiotensin-converting enzyme
ACS
acute coronary syndrome
ATE
arterial thrombotic event
ATP
adenosine triphosphate
CMP
cardiomyopathy
CTCL
cutaneous T-cell lymphoma
DVT
deep vein thrombosis
FDA
Food and Drug Administration
HF
heart failure
HTN
hypertension
LMWH
low-molecular-weight heparin
LVD
left ventricular dysfunction
LVEF
left ventricular ejection fraction
MI
myocardial infarction
MUGA
multigated acquisition scan
PE
pulmonary embolism
VEGF
vascular endothelial growth factor
VTE
venous thromboembolism
5-FU
5-fluorouracil
Cited by (0)
Dr. Yeh is a consultant for Celgene and is the McNair Scholar of the Texas Heart Institute.
Copyright © 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.